Intelence (etravirine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intelence (etravirine), covering 2011-06-15 to 2011-06-15. Get the full timeline:
Most recent: Clinical Trial Update: TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options. [Phase 3]